年轻人结肠直肠癌:撒哈拉以南非洲国家的5年研究
Efared Boubacar1,2, Abani Bako Aïchatou Balaraba3,4, Boubacar Idrissa5
1Département des Sciences Fondamentales et Mixtes, Faculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger. befared2013@gmail.com.
BMC gastroenterology
|November 28, 2025
概括
结肠直肠癌 (CRC) 在撒哈拉以南非洲影响了大量年轻人. 年轻的CRC患者往往表现出较差的预后特征,强调了早期查策略的必要性.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 结肠直肠癌 (CRC) 是一个全球性的健康问题,年轻人群中的发病率正在上升.
- 本研究侧重于撒哈拉以南非洲国家CRC趋势,比较年轻和老年患者的人口统计.
研究的目的:
- 对45岁以下的患者进行结直肠癌 (CRC) 的比较分析,与45岁及以上的患者进行比较分析.
- 在撒哈拉以南非洲的背景下,确定与年轻人中CRC发生相关的风险因素.
主要方法:
- 在5年时间内诊断出173例结直肠癌 (CRC) 病例的回顾性分析.
- 较年轻 (≥45岁) 和较年长 (≥45岁) CRC 患者之间的临床病理特征的统计比较.
- 统变逻辑回归用于确定年轻患者CRC的风险因素.
主要成果:
- 结肠直肠癌 (CRC) 是第三常见的癌症,其中39.9%的病例发生在45岁以下的患者中.
- 年轻女性 (43.5%) 患CRC更为普遍,并且经常与粘膜或结环细胞癌 (SRC) 组织学相关 (21.7%).
- 女性性别 (OR=1.9) 和粘膜/SRC组织学 (OR=4.59) 被确定为年轻患者CRC的危险因素.
结论:
- 结肠直肠癌 (CRC) 显著影响该地区的年轻人,强调了早期查的重要性.
- 与老年患者相比,年轻的CRC患者呈现出明显的,往往不良的临床病理特征.
更多相关视频
07:35Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
7.3K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
472
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
